← Back to Search

EMDR for Suicidal Thoughts

N/A

Recruiting

Led By Lisa M Burback, MD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults aged 18 to 65 with suicidal ideation in the last week

adults (ages 18 to 65) with suicidal ideation in the last week.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up comparing one year before to one year after study enrolment.

Awards & highlights

Study Summary

This trial will test whether a specific type of therapy - Eye Movement Desensitization and Reprocessing (EMDR) - is safe and effective for reducing suicidal thoughts in adults.

Who is the study for?

Adults aged 18-65 with recent suicidal thoughts can join this trial if they have a primary care provider, can consent to treatment, and commit to twice-weekly sessions for 12 total. They need their own computer with camera/mic and a private space. They must avoid certain drugs before/after sessions.Check my eligibility

What is being tested?

The trial is testing virtual EMDR therapy's safety and effectiveness against usual care in reducing suicidal ideation. Participants are randomly assigned to either receive EMDR plus usual care or just the usual care, comparing mental health outcomes pre- and post-treatment.See study design

What are the potential side effects?

Potential side effects of EMDR may include temporary increases in distress, vivid dreams, light-headedness during sessions, emergence of new traumatic memories, or changes in emotions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old and have had thoughts of suicide in the past week.

Select...

I am between 18 and 65 years old and have had thoughts of suicide in the past week.

Select...

I have a computer with a camera and microphone for therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ comparing one year before to one year after study enrolment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~comparing one year before to one year after study enrolment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and comparing one year before to one year after study enrolment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Beck Scale for Suicide ideation (BSS)

Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)

Secondary outcome measures

ACES Questionnaire (ACES)

BDI II (Beck Depression Inventory II)

DERS (Difficulties in Emotion Regulation Scale)

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Virtual EMDRExperimental Treatment2 Interventions

Patients will receive 1 to 3 preparation sessions (which will include psychoeducation and preparation exercises before EMDR), followed by up to 12 EMDR sessions, delivered over encrypted Zoom videoconferencing. EMDR is an evidence based trauma therapy. These EMDR sessions will focus on the experiences, urges or negative thoughts associated with their suicidal thoughts. The sessions will be 90 minutes in length and occur twice per week. This group will also have access to usual psychiatric care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.

Group II: Treatment as usualActive Control1 Intervention

This group will also have access to usual care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Eye Movement Desensitization and Reprocessing (EMDR)

2010

N/A

~60

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,866 Total Patients Enrolled

Alberta Health servicesOTHER

157 Previous Clinical Trials

649,502 Total Patients Enrolled

Lisa M Burback, MDPrincipal InvestigatorUniversity of Alberta

Media Library

EMDR Clinical Trial Eligibility Overview. Trial Name: NCT04181047 — N/A

Suicidal Thoughts Research Study Groups: Virtual EMDR, Treatment as usual

Suicidal Thoughts Clinical Trial 2023: EMDR Highlights & Side Effects. Trial Name: NCT04181047 — N/A

EMDR 2023 Treatment Timeline for Medical Study. Trial Name: NCT04181047 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What goals are researchers hoping to accomplish with this medical trial?

"The primary outcome to be measured over 4 months after baseline is the Columbia Suicide Severity Rating Scale (CSSRS) Recent, which involves a self-assessment of the past week. Secondary outcomes include Generalized Anxiety Disorder 7 (GAD 7), Patient Health Questionnaire 9 (PHQ-9), and Dissociative Experiences Scale II (DES II). GAD 7 consists of questions ranked from 0 to 3 with scores ranging from 0 to 21; PHQ-9 has nine items rated on a scale of 0 to 3 whose total score ranges from 0 to 27; DES II is composed of 28 items scored between 0 and 100"

Answered by AI

What is the upper limit of participants for this trial?

"Confirmed. Clinicaltrials.gov hosts the information that this research initiative, which was initially posted on April 12th 2021, is in search of participants. The study needs to recruit 80 individuals from 2 separate medical facilities."

Answered by AI

What criteria must potential participants fulfill to be eligible for this investigation?

"Candidates that display suicidal tendencies and fall within the age range of 18 to 65 can apply for this clinical trial. Our team is currently searching for 80 participants in total."

Answered by AI

Does this experiment extend to individuals older than 20 years of age?

"The prescribed parameters for participant enrollment in this trial lists the minimum age as 18 and the maximum age as 65."

Answered by AI

Is this investigation accepting new participants at present?

"Affirmative, the clinicaltrials.gov website asserts that this research is currently enrolling participants. It was inaugurated on April 12th 2021 and most recently updated October 5th 2022. 80 individuals need to be recruited between two separate study sites."

Answered by AI